Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Bio Rad Laboratories Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Bio Rad Laboratories Inc tiene un total de activos de $9,364, una ganancia neta loss de $-1,844

Question 2

¿Cuáles son los ratios financieros clave para BIO?

Accepted Answer

El ratio corriente de Bio Rad Laboratories Inc es 3.35, el margen neto es -71.86, las ventas por acción son $90.94.

Question 3

¿Cómo se desglosan los ingresos de Bio Rad Laboratories Inc por segmento o geografía?

Accepted Answer

Bio Rad Laboratories Inc largest revenue segment is Life Science, at a revenue of 1,028,100,000 in the most earnings release.For geography, United States is the primary market for Bio Rad Laboratories Inc, at a revenue of 1,041,500,000.

Question 4

¿Es rentable Bio Rad Laboratories Inc?

Accepted Answer

no, según los últimos estados financieros, Bio Rad Laboratories Inc tiene una ganancia neta loss de $-1,844

Question 5

¿Tiene Bio Rad Laboratories Inc alguna deuda?

Accepted Answer

yes, Bio Rad Laboratories Inc tiene una deuda de 2,794

Question 6

¿Cuántas acciones en circulación tiene Bio Rad Laboratories Inc?

Accepted Answer

Bio Rad Laboratories Inc tiene un total de acciones en circulación de 28.01

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,557	2,566	2,671	2,802	2,922	2,545
Revenue Growth (YoY)	-1%	-4%	-5%	-4%	15%	10%
Cost of Revenue	1,216	1,187	1,240	1,233	1,259	1,107
Gross Profit	1,340	1,378	1,430	1,568	1,663	1,437
Selling, General & Admin	806	814	824	824	851	798
Research & Development	271	266	240	256	247	217
Operating Expenses	1,078	1,080	1,065	1,081	1,098	1,016
Other Non Operating Income (Expenses)	0	1	4	-2	0	-1
Pretax Income	-842	-2,342	-850	-4,704	5,449	4,918
Income Tax Expense	-166	-498	-212	-1,076	1,194	1,103
Net Income	-675	-1,844	-637	-3,627	4,254	3,814
Net Income Growth	-13%	189%	-82%	-185%	12%	117%
Shares Outstanding (Diluted)	26.92	28.21	29.2	29.8	30.2	30.2
Shares Change (YoY)	-4%	-3%	-2%	-1%	0%	0%
EPS (Diluted)	-25.1	-65.36	-21.81	-121.72	140.87	126.29
EPS Growth	-10%	200%	-82%	-186%	12%	117%
Free Cash Flow	336	266	218	81	535	476
Free Cash Flow Per Share	12.48	9.42	7.46	2.71	17.71	15.76
Gross Margin	52.4%	53.7%	53.53%	55.96%	56.91%	56.46%
Operating Margin	10.24%	11.61%	13.66%	17.34%	19.3%	16.54%
Profit Margin	-26.39%	-71.86%	-23.84%	-129.44%	145.58%	149.86%
Free Cash Flow Margin	13.14%	10.36%	8.16%	2.89%	18.3%	18.7%
EBITDA	--	301	371	--	--	--
EBITDA Margin	--	11.73%	13.88%	--	--	--
D&A For EBITDA	--	3	6	--	--	--
EBIT	262	298	365	486	564	421
EBIT Margin	10.24%	11.61%	13.66%	17.34%	19.3%	16.54%
Effective Tax Rate	19.71%	21.26%	24.94%	22.87%	21.91%	22.42%

Bio Rad Laboratories Inc (BIO) Price

BIO Stock Price Chart

BIO Income

Follow-Up Questions